scholarly article | Q13442814 |
P50 | author | Michael E Jones | Q92480941 |
Penny Coulson | Q114337675 | ||
Parichoy Pal Choudhury | Q117276789 | ||
Montserrat García-Closas | Q28356305 | ||
Minouk J Schoemaker | Q37371896 | ||
Mark N Brook | Q57517906 | ||
Anthony Swerdlow | Q60492223 | ||
Nick Orr | Q78318000 | ||
Gail Mitchell | Q87048867 | ||
Amber Wilcox | Q89547723 | ||
P2093 | author name string | Thomas Ahearn | |
Nilanjan Chatterjee | |||
Yan Zhang | |||
P2860 | cites work | Performance of BCRAT in high-risk patients with breast cancer | Q92510711 |
Performance of BCRAT in high-risk patients with breast cancer - Authors' reply | Q92510717 | ||
Generalized meta-analysis for multiple regression models across studies with disparate covariate information | Q92711008 | ||
The impact of a panel of 18 SNPs on breast cancer risk in women attending a UK familial screening clinic: a case-control study | Q27644636 | ||
Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial. | Q30238753 | ||
Developing and evaluating polygenic risk prediction models for stratified disease prevention | Q30251440 | ||
External validation of multivariable prediction models: a systematic review of methodological conduct and reporting | Q30577024 | ||
Constrained Maximum Likelihood Estimation for Model Calibration Using Summary-level Information from External Big Data Sources | Q31124729 | ||
Validation of the Gail et al. model of breast cancer risk prediction and implications for chemoprevention | Q32133889 | ||
An assessment of existing models for individualized breast cancer risk estimation in a screening program in Spain | Q33643562 | ||
Breast cancer risk assessment across the risk continuum: genetic and nongenetic risk factors contributing to differential model performance | Q33739374 | ||
Effect of changing breast cancer incidence rates on the calibration of the Gail model | Q33897605 | ||
Decision curve analysis revisited: overall net benefit, relationships to ROC curve analysis, and application to case-control studies | Q33940145 | ||
Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information | Q34267477 | ||
Combined associations of genetic and environmental risk factors: implications for prevention of breast cancer | Q34736112 | ||
Mammographic breast density refines Tyrer-Cuzick estimates of breast cancer risk in high-risk women: findings from the placebo arm of the International Breast Cancer Intervention Study I. | Q35000324 | ||
Evaluation of breast cancer risk assessment packages in the family history evaluation and screening programme | Q35441054 | ||
The contributions of breast density and common genetic variation to breast cancer risk | Q36137764 | ||
SNPs and breast cancer risk prediction for African American and Hispanic women | Q36322904 | ||
Mammographic density adds accuracy to both the Tyrer-Cuzick and Gail breast cancer risk models in a prospective UK screening cohort | Q36336239 | ||
Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis | Q36507079 | ||
Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
Assessing the performance of prediction models: a framework for traditional and novel measures | Q36617895 | ||
Breast Cancer Risk Prediction Using Clinical Models and 77 Independent Risk-Associated SNPs for Women Aged Under 50 Years: Australian Breast Cancer Family Registry | Q36619329 | ||
Recalibration of the Gail model for predicting invasive breast cancer risk in Spanish women: a population-based cohort study | Q36649796 | ||
Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies | Q37059182 | ||
Using clinical factors and mammographic breast density to estimate breast cancer risk: development and validation of a new predictive model | Q37172219 | ||
Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model | Q37246495 | ||
Evaluating breast cancer risk projections for Hispanic women | Q37307773 | ||
Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies | Q37364628 | ||
Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes | Q37444608 | ||
A systematic review of breast cancer incidence risk prediction models with meta-analysis of their performance | Q37950847 | ||
Risk prediction models of breast cancer: a systematic review of model performances | Q37955078 | ||
Comparison of approaches for incorporating new information into existing risk prediction models | Q39108831 | ||
Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications. | Q39263736 | ||
Practice Bulletin Number 179: Breast Cancer Risk Assessment and Screening in Average-Risk Women | Q39394075 | ||
Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States | Q39734134 | ||
Breast cancer risk prediction using a clinical risk model and polygenic risk score | Q40605693 | ||
Assessing breast cancer risk models in Marin County, a population with high rates of delayed childbirth. | Q45956105 | ||
Association analysis identifies 65 new breast cancer risk loci. | Q45979098 | ||
Mammographic breast density and the Gail model for breast cancer risk prediction in a screening population. | Q45990033 | ||
Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer | Q46103372 | ||
Predicting risk of breast cancer in postmenopausal women by hormone receptor status | Q46901894 | ||
Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium | Q47190168 | ||
Impact of a Panel of 88 Single Nucleotide Polymorphisms on the Risk of Breast Cancer in High-Risk Women: Results From Two Randomized Tamoxifen Prevention Trials. | Q48717652 | ||
Use of Single-Nucleotide Polymorphisms and Mammographic Density Plus Classic Risk Factors for Breast Cancer Risk Prediction. | Q49964811 | ||
Validation of the Gail et al. model for predicting individual breast cancer risk. | Q50603613 | ||
Projecting absolute invasive breast cancer risk in white women with a model that includes mammographic density. | Q51933968 | ||
A breast cancer prediction model incorporating familial and personal risk factors. | Q52000310 | ||
Gail Model for Prediction of Absolute Risk of Invasive Breast Cancer: Independent Evaluation in the Florence–European Prospective Investigation Into Cancer and Nutrition Cohort | Q56836342 | ||
Cost-effectiveness and Benefit-to-Harm Ratio of Risk-Stratified Screening for Breast Cancer: A Life-Table Model | Q57177092 | ||
Decision curve analysis: a technical note | Q58804823 | ||
Prospective validation of the NCI Breast Cancer Risk Assessment Tool (Gail Model) on 40,000 Australian women | Q60942791 | ||
Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes | Q62583133 | ||
Reproductive Factors and Mammographic Density: Associations Among 24,840 Women and Comparison of Studies Using Digitized Film-Screen Mammography and Full-Field Digital Mammography | Q64113573 | ||
10-year performance of four models of breast cancer risk: a validation study | Q64115284 | ||
Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk | Q64279327 | ||
Projecting individualized probabilities of developing breast cancer for white females who are being examined annually | Q69396132 | ||
Polygenic susceptibility to breast cancer and implications for prevention | Q78029012 | ||
Long-term Accuracy of Breast Cancer Risk Assessment Combining Classic Risk Factors and Breast Density | Q88282837 | ||
The personal and clinical utility of polygenic risk scores | Q88778863 | ||
iCARE: An R package to build, validate and apply absolute risk models | Q89547730 | ||
Estimation of complex effect-size distributions using summary-level statistics from genome-wide association studies across 32 complex traits | Q90929499 | ||
Assessment of breast cancer risk: which tools to use? | Q91866775 | ||
P433 | issue | 3 | |
P304 | page(s) | 278-285 | |
P577 | publication date | 2020-03-01 | |
P1433 | published in | Journal of the National Cancer Institute | Q400279 |
P1476 | title | Comparative Validation of Breast Cancer Risk Prediction Models and Projections for Future Risk Stratification | |
P478 | volume | 112 |
Q91388567 | Application of convolutional neural networks to breast biopsies to delineate tissue correlates of mammographic breast density |
Q90300115 | Choosing Breast Cancer Risk Models: Importance of Independent Validation |
Q96577447 | Distinct temporal trends in breast cancer incidence from 1997 to 2016 by molecular subtypes: a population-based study of Scottish cancer registry data |
Q90814829 | Electronic health records and polygenic risk scores for predicting disease risk |
Q90300125 | Performance of breast cancer risk assessment models in a large mammography cohort |
Q96577047 | Personalized early detection and prevention of breast cancer: ENVISION consensus statement |
Q91788154 | Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers |
Q98611548 | Polygenic background modifies penetrance of monogenic variants for tier 1 genomic conditions |
Q89511306 | Using Whole Breast Ultrasound Tomography to Improve Breast Cancer Risk Assessment: A Novel Risk Factor Based on the Quantitative Tissue Property of Sound Speed |
Search more.